This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Genzyme: Analysts' Upgrades, Downgrades

Nvidia (NVDA) estimates, target increased at Goldman. Shares of NVDA now seen reaching $16. Estimates also boosted, to reflect the company's higher gross margin. Neutral rating.

OfficeMax (OMX) estimates, target raised at Goldman. Shares of OMX now seen reaching $17.50. Estimates also upped, as the company is seeing better sales. Buy rating. (PCLN) target, estimates boosted at BofA/Merrill. PCLN price target increased to $300 from $228 on higher estimates. Estimates raised through 2011. Maintain Buy rating. (PCLN) numbers raised at Goldman. Shares of PCLN now seen reaching $265. Estimates also boosted, given better sales in Europe. Buy rating.

Phillips-Van Heusen (PVH) numbers increased at Morgan Stanley. Shares of PVH now seen reaching $51. Estimates also upped, as the company is seeing better demand across the board. Overweight rating.

Cimarex Energy (XEC) estimates raised at Morgan Stanley through 2011. Company is seeing better production from it new wells in the Gulf Coast. Overweight rating and $65 price target.
This article was written by a staff member of
5 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AEO $14.23 -0.84%
BHI $45.43 0.84%
AMAT $19.75 -0.50%
DE $81.38 0.22%
HPQ $11.47 0.17%


Chart of I:DJI
DOW 17,651.43 -9.28 -0.05%
S&P 500 2,041.82 -8.81 -0.43%
NASDAQ 4,690.20 -26.8940 -0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs